Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MEETINGS - North American Society of Pacing and Electrophysiology holds Annual Scientific Sessions (US) May 2000:

This article was originally published in Clinica

Executive Summary

The North American Society of Pacing and Electrophysiology (NASPE) will hold its 21st Annual Scientific Sessions in Washington, DC, in the US on May 17-20. Areas to covered will include: the role of the implantable cardioverter defibrillator in the year 2000; correct coding for electrophysiology procedures and device implications: achieving appropriate reimbursement; what can computer simulations teach the cardiac electrophysiologist; non-invasive tests to identify at-risk family members of patients with arrhythmias; and cardiac pacing to prevent atrial defibrillation. For more information contact NASPE in the US. Tel: +1 508 647 0100. Fax: +1 617 630 1325

You may also be interested in...

India Rare Disease Policy Proposes Crowdfunding But Patients Feel Let Down

Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.

India’s Hilleman Plans ‘Affordable’ Vaccine Against Group B Strep

India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.

More Surufatinib Cheer For Chi-Med As Second NET Trial Stopped Early

Chi-Med’s surufatinib has come up trumps in a second trial in neuroendocrine tumors, after the monitoring committee recommended an early halt following achievement of its PFS target in the pancreatic setting.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts